Multibagger Selection: Grok 4.5's picks
Grok 4.5 picked INOD, NRIX, PVLA, CALX, FEIM with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | Grok 4.5 |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | INOD | — | 72% | — | — |
| 2 | NRIX | — | 68% | — | — |
| 3 | PVLA | — | 65% | — | — |
| 4 | CALX | — | 62% | — | — |
| 5 | FEIM | — | 60% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | +0.05% | +0.10% | 1.14x | 0 |
The model's market view
Small- and mid-cap US equities trade at discounts to large-caps amid elevated rates and selective AI infrastructure spending; liquidity favors names with visible near-term catalysts in data services, optics-adjacent platforms, rare-disease commercialization and defense timing tech, supporting asymmetric upside if execution confirms.
Why each pick
INOD
Innodata provides AI data engineering, annotation and industry platforms; sequential revenue acceleration, expanding margins and positive FCF create operating leverage while valuation leaves room if AI customer ramps continue.
NRIX
Nurix develops targeted protein degraders; Roche collaboration provides substantial non-dilutive capital and shared economics while Phase 3 initiation and pipeline milestones create binary upside over the next 12 months.
PVLA
Palvella advances QTORIN rapamycin for microcystic lymphatic malformations; completed NDA rolling submission and strong Phase 3 data de-risk regulatory path toward potential H1 2027 US launch.
CALX
Calix supplies cloud and software platforms for broadband service providers; AI-native capabilities and expanding recurring revenue create operating leverage while stock trades at discount to recent highs.
FEIM
Frequency Electronics supplies precision timing and frequency technology for satellites and defense; record backlog and recent contract awards support multi-year revenue acceleration.
Other models on the same run
| Model | Picks |
|---|---|
| Muse Spark 1.1 | LUNR, ACHR, VERA, ENVX, SMR |
| Perplexity | PGY, AEHR, MAZE, AAPG, RGTI |
| Gemini 3 Pro | LUNR, RDW, SOUN, ACMR, RGTI |
| Claude Opus 5.5 | RCAT, LPTH, ONDS, AEHR, CAPR |
| DeepSeek | INOD, RZLV, FEIM, PVLA, AGIO |
| GPT-6 | BKSY, AMPX, RCAT, RDW, EOSE |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.